| HCPCS Code | Code Dosage | Payment Limit |
Vaccine AWP % | Vaccine Limit | Infusion AWP % | DME infusion limit | Blood AWP % | Blood limit | Clotting factor | Note |
|---|---|---|---|---|---|---|---|---|---|---|
J9042 - Injection, brentuximab vedotin, 1 mg |
1 MG | 196.653 | - | - | - | - | - | - | ||
J9043 - Injection, cabazitaxel, 1 mg |
1 MG | 190.948 | - | - | - | - | - | - | ||
J9044 - Injection, bortezomib, not otherwise specified, 0.1 mg |
0.1 MG | 15.659 | - | - | - | - | - | - | ||
J9045 - Injection, carboplatin, 50 mg |
50 MG | 2.768 | - | - | - | - | - | - | ||
J9047 - Injection, carfilzomib, 1 mg |
1 MG | 41.335 | - | - | - | - | - | - | ||
J9050 - Injection, carmustine, 100 mg |
100 MG | 801.095 | - | - | - | - | - | - | ||
J9055 - Injection, cetuximab, 10 mg |
10 MG | 67.642 | - | - | - | - | - | - | ||
J9060 - Injection, cisplatin, powder or solution, 10 mg |
10 MG | 1.929 | - | - | - | - | - | - | ||
J9061 - Injection, amivantamab-vmjw, 2 mg |
2 MG | 17.896 | - | - | - | - | - | - | ||
J9065 - Injection, cladribine, per 1 mg |
1 MG | 17.696 | - | - | - | - | - | - | ||
J9070 - Cyclophosphamide, 100 mg |
100 MG | 23.88 | - | - | - | - | - | - | ||
J9100 - Injection, cytarabine, 100 mg |
100 MG | 1.042 | - | - | - | - | - | - | ||
J9119 - Injection, cemiplimab-rwlc, 1 mg |
1 MG | 27.623 | - | - | - | - | - | - | ||
J9120 - Injection, dactinomycin, 0.5 mg |
0.5 MG | 809.056 | - | - | - | - | - | - | ||
J9130 - Dacarbazine, 100 mg |
100 MG | 5.535 | - | - | - | - | - | - | ||
J9144 - Injection, daratumumab, 10 mg and hyaluronidase-fihj |
10 MG | 44.877 | - | - | - | - | - | - | ||
J9145 - Injection, daratumumab, 10 mg |
10 MG | 56.684 | - | - | - | - | - | - | ||
J9150 - Injection, daunorubicin, 10 mg |
10 MG | 39.577 | - | - | - | - | - | - | ||
J9153 - Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine |
1 MG/2.27 MG | 212.829 | - | - | - | - | - | - | ||
J9155 - Injection, degarelix, 1 mg |
1 MG | 4.049 | - | - | - | - | - | - | ||
J9171 - Injection, docetaxel, 1 mg |
1 MG | 0.473 | - | - | - | - | - | - | ||
J9173 - Injection, durvalumab, 10 mg |
10 MG | 77.107 | - | - | - | - | - | - | ||
J9176 - Injection, elotuzumab, 1 mg |
1 MG | 6.859 | - | - | - | - | - | - | ||
J9177 - Injection, enfortumab vedotin-ejfv, 0.25 mg |
0.25 MG | 31.336 | - | - | - | - | - | - | ||
J9178 - Injection, epirubicin hcl, 2 mg |
2 MG | 1.656 | - | - | - | - | - | - | ||
| * Effective April 1, 2022 through June 30, 2022 | ||||||||||
Medicare Part B payment allowance limits for drugs not otherwise classified - Effective April 1, 2022 through June 30, 2022
| Drug name | Dosage | Payment limit | Notes |
|---|---|---|---|
| Alfentanil Hcl | 500 MCG | 1.996 | |
| Allopurinol Sodium | 500 MG | 2676.366 | |
| Aminocaproic acid | 250 MG | 0.292 | |
| Aztreonam | 500 MG | 13.886 | |
| Bumetanide | 0.25 MG | 0.331 | |
| Bupivacaine | 1 ML | 0.101 | |
| Clindamycin Phosphate | 150 MG | 0.966 | |
| Coagulation Factor IX, Recombinant (Ixinity) | 1 IU | 1.782 | includes clotting factor furnishing fee |
| Diltiazem Hydrochloride | 5 MG | 0.282 | |
| Doxycycline Hyclate | 100 MG | 16.75 | |
| Esmolol Hydrochloride | 10 MG | 0.321 | |
| Famotidine | 10 MG | 0.372 | |
| Flumazenil | 0.1 MG | 0.794 | |
| Folic Acid | 5 MG | 2.975 | |
| Glucarpidase | 10 UNITS | 362.572 | |
| Glycopyrrolate injection | 0.2 MG | 1.999 | |
| Immune Globulin (Cutaquig) | 100 MG | 12.768 | |
| Immune Globulin (Panzyga) | 500 MG | 75.135 | |
| Labetalol Hcl | 5 MG | 0.204 | |
| Metoprolol Tartrate | 1 MG | 0.128 | |
| Metronidazole inj | 500 MG | 1.145 | |
| Nitroglycerin | 5 MG | 1.292 | |
| Olanzapine short acting intramuscular injection | 0.5 MG | 0.89 | |
| Paliperidone Palmitate (Invega Trinza) | 1 MG | 10.688 | |
| Rifampin | 600 MG | 88.89 | |
| Sodium Chloride, Hypertonic (3% - 5% infusion) | 250 CC | 1.447 | |
| Sulfamethoxazole-Trimethoprim | 400-80 MG | 0.642 | |
| Vasopressin | 20 UNITS | 219.462 |